DEBRA TOOKER: Open Payments
NPI 1164728739 · ROGERS, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$362 in 11 payments from 10 companies in 2025. Trend: 2023 $428 · 2024 $121 · 2025 $362
Food & beverage: $263Education: $99
| Company | Payments | Amount |
|---|---|---|
| PharmaEssentia USA Corporation | 1 | $121 |
| Gilead Sciences, Inc. | 1 | $99 |
| Novartis Pharmaceuticals Corporation | 2 | $30 |
| Geron Corporation | 1 | $19 |
| Janssen Biotech, Inc. | 1 | $18 |
| GENZYME CORPORATION | 1 | $16 |
| Aveo Pharmaceuticals, Inc. | 1 | $15 |
| Incyte Corporation | 1 | $15 |
| Regeneron Healthcare Solutions, Inc. | 1 | $14 |
| ABBVIE INC. | 1 | $14 |
Products named: BESREMI, Trodelvy, RYTELO, RYBREVANT, SARCLISA, Fabhalta, FOTIVDA, MONJUVI.
Industry payments across AR — which companies pay providers there.
